| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/29/2004 | US20040081689 Activating a fluid ejector actuator to eject a bioactive fluid onto at least a portion of an interior surface of said enclosing medium |
| 04/29/2004 | US20040081673 Compositions and methods for the treatment of skin damage |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2502505A1 Alpha-phenyl acetanilide derivatives and their human therapeutic application |
| 04/29/2004 | CA2502356A1 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/28/2004 | EP1413579A1 Imidazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/28/2004 | EP1413434A1 Pharmaceutical dosage form and method of making |
| 04/28/2004 | EP1413331A2 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) for vascular indications |
| 04/28/2004 | EP1413313A1 DIAGNOSIS AND TREATMENT OF INSULIN−DEPENDENT DIABETES MELLITUS AND INSULITIS |
| 04/28/2004 | EP1413311A1 Compositions for nasal administration of insulin |
| 04/28/2004 | EP1413309A1 Drugs for ameliorating postcibal hyperglycemia |
| 04/28/2004 | EP1413308A1 Hypoglycemic agent |
| 04/28/2004 | EP1413303A1 Swine growth promoters and method of promoting swine growth |
| 04/28/2004 | EP1413295A1 Sustained release composition for oral administration of drugs |
| 04/28/2004 | EP1412529A2 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412386A2 USE OF PEPTIDE FRAGMENTS OF THE CALCIUM CHANNEL $g(A)-1 SUBUNIT, OPTIONALLY COMPRISING MUTATIONS, FOR SCREENING MOLECULES OF THERAPEUTIC INTEREST |
| 04/28/2004 | EP1412385A2 Modified insulin with reduced immunogenicity |
| 04/28/2004 | EP1412384A2 Stable formulation of modified glp-1 |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 04/28/2004 | EP1412357A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412326A1 Butyric acid derivatives |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 04/28/2004 | EP1411986A1 Composition for epigallocatechin gallate |
| 04/28/2004 | EP1411984A2 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 04/28/2004 | EP1411969A1 Modified protamine with reduced immunogenicity |
| 04/28/2004 | EP1411968A2 Glp-1 exendin-4 peptide analogs and uses thereof |
| 04/28/2004 | EP1411960A1 Fortified rice bran food product and method for promoting cardiovascular health |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411952A1 Use of at least one glycoinhibitor substance |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411943A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1411925A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 04/28/2004 | EP1411923A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 04/28/2004 | EP1411919A1 (-)-olivil as antioxidant |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411895A2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP1411780A1 Soluble roasted chicory with high inulin content |
| 04/28/2004 | EP1294682B1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 04/28/2004 | EP1206448B1 Novel vitamin d analogues |
| 04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 04/28/2004 | EP1135124B1 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituded indolealkanoic acids |
| 04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/28/2004 | EP1061946B1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0937045B1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 04/28/2004 | CN1492930A Anti-interferon-šŒantibodies |
| 04/28/2004 | CN1492927A Human FGF23 protein mutant lowering blood phosphorus level |
| 04/28/2004 | CN1492873A Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/28/2004 | CN1492871A Isoxazoline derivatives as anti-depressants |
| 04/28/2004 | CN1492870A Xanthine derivative, production and use thereof as a medicament |
| 04/28/2004 | CN1492865A š�-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same |
| 04/28/2004 | CN1492766A Prevention of diabetes by administration of GnRH antagonists |
| 04/28/2004 | CN1492762A Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | CN1491715A Chewing tablet of fleece-flower root and preparing method |
| 04/28/2004 | CN1491697A Chinese medicine preparation for treatnig diabetes and its preparing method |
| 04/28/2004 | CN1491674A Arctium fruit general lignin glycoside extracts for treating diabetic nephrosis or diabete |
| 04/28/2004 | CN1491672A Organic state micro element supplement agent |
| 04/28/2004 | CN1491668A Composition of stachyose and bee product |
| 04/28/2004 | CN1491646A Compound amino acid ferrous salt iron supplement agent and its producing method |
| 04/28/2004 | CN1491639A Blood sugar reducing skin-care cream specially for curing diabetes and its producing method |
| 04/28/2004 | CN1147495C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 04/28/2004 | CN1147482C Substittued (dihydro) benzoxazole and (dihydro)benzoxazine compound and its preparation and medicine composite |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147470C Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicine |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/28/2004 | CN1147306C Hydration compositions for human or animal bodies |
| 04/28/2004 | CN1147303C Application of Breviscapine in preparing medicine |
| 04/27/2004 | US6727274 Use in treating conditions in which 5-ht6 receptors are involved such as anxiety, depression, schizophrenia, alzheimer's disease, stress-related disease, nervous system disorders; use in performing positron emission tomography |
| 04/27/2004 | US6727270 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727261 Pyrido[2,1-A]Isoquinoline derivatives |
| 04/27/2004 | US6727258 Allosteric adenosine receptor modulators |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6726905 Lowering serum phosphate |
| 04/27/2004 | CA2187394C Diabetic nutritional product having controlled absorption of carbohydrate |
| 04/24/2004 | CA2446094A1 Pharmaceutical dosage form and method of making |
| 04/23/2004 | CA2445817A1 Novel derivatives of imidazoline, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2004 | WO2004033688A1 Cap-binding protein |
| 04/22/2004 | WO2004033502A1 Chitosan-containing polysaccharide, process for producing the same and use thereof |
| 04/22/2004 | WO2004033438A1 Novel heterocyclic analogs of diphenylethylene compounds |
| 04/22/2004 | WO2004033431A2 Hydroxypyrazoles for use against metabolic-related disorders |
| 04/22/2004 | WO2004033416A2 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 04/22/2004 | WO2004032968A1 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity |